Animal Health Solutions

Broadest * parasite coverage available in an isoxazoline endectocide covering 7 types of parasites † FLEAS ROUNDWORMS TICKS HOOKWORMS HEARTWORM DISEASE TAPEWORMS NEW WORLD SCREWWORM § Other Chewables ‡ Order Credelio Quattro/Credelio Quattro Learn more at Covetrus.vet/Quattro Prescribe your patients the * Based on label comparison of the number of parasite types covered in an isoxazoline endectocide. † Credelio Quattro protects dogs against ticks, fleas, heartworm disease, roundworms, hookworms, and tapeworms. Credelio Quattro-CA1 is conditionally approved for the treatment of New World screwworm larvae infestations in dogs pending a full demonstration of effectiveness. ‡ Other chewables in the isoxazoline endectocide drug class. § Credelio Quattro-CA1 is conditionally approved by FDA pending a full demonstration of effectiveness under application number 141-619. (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets) Indications: Credelio Quattro is indicated for the prevention of heartworm disease caused by Dirofilaria immitis and for the treatment and control of roundworm (immature adult and adult Toxocara canis and adult Toxascaris leonina), hookworm (fourth stage larvae, immature adult, and adult Ancylostoma caninum and adult Uncinaria stenocephala), and tapeworm (Dipylidium caninum, Taenia pisiformis, and Echinococcus granulosus) infections. Credelio Quattro kills adult fleas and is indicated for the treatment and prevention of flea infestations (Ctenocephalides felis) and the treatment and control of tick infestations [Amblyomma americanum (lone star tick), Dermacentor variabilis (American dog tick), Ixodes scapularis (black-legged tick), Rhipicephalus sanguineus (brown dog tick), and Haemaphysalis longicornis (longhorned tick)] for one month in dogs and puppies 8 weeks of age and older, and weighing 3.3 pounds or greater. Credelio Quattro is indicated for the prevention of Borrelia burgdorferi infections (also known as Lyme disease) as a direct result of killing Ixodes scapularis vector ticks. Credelio Quattro-CA1 is conditionally approved for the treatment of infestations caused by New World screwworm (NWS; Cochliomyia hominivorax) larvae (myiasis) in dogs and puppies 8 weeks of age and older and weighing 3.3 pounds or greater. Important Safety Information: Lotilaner, an ingredient in Credelio Quattro/Credelio Quattro-CA1, belongs to the isoxazoline class and has been associated with neurologic adverse reactions like tremors, ataxia, and seizures even in dogs without a history of seizures. Use with caution in dogs with a history of seizures or neurologic disorders. Dogs should be tested for existing heartworm infections before Credelio Quattro/Credelio Quattro-CA1 administration as it is not effective against adult D. immitis. The safe use in breeding, pregnant, or lactating dogs has not been evaluated. The most frequently reported adverse reactions in clinical trials were vomiting and diarrhea. Credelio Quattro-CA1 is conditionally approved by the FDA pending a full demonstration of effectiveness under application number 141-619. Treatment of NWS myiasis includes removal of the larvae, lesion cleaning and surgical debridement. Implement appropriate wound care and pain management. For full prescribing information, see the Credelio Quattro/Credelio Quattro-CA1 package insert. Credelio Quattro, Elanco, and the diagonal bar logo are trademarks of Elanco or its affiliates. ©2026 Elanco or its affiliates. PM-US-25-0357(3) Credelio Credelio Y 6.1 - 12 Dogs & Puppies 8 weeks of age and older Credelio Credelio Quattro Quattro-CA1 (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets) Fleas New World Screwworm" © Heartworms is approved by FD, pending a demonstration ofeffectiveness under application number 141-619. flavored chewable tablets i= Elanco Elanco WL

• Cover